Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy

CompletedOBSERVATIONAL
Enrollment

353

Participants

Timeline

Start Date

October 13, 2016

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Locally Advanced or Metastatic Breast Cancer
Interventions
DRUG

Eribulin

Trial Locations (65)

Unknown

Eisai Trial Site 1, Amberg

Eisai Trial Site 1, Aschaffenburg

Eisai Trial Site 2, Aschaffenburg

Eisai Trial Site 1, Augsburg

Eisai Trial Site 2, Augsburg

Eisai Trial Site 1, Aurich

Eisai Trial Site 1, Berlin

Eisai Trial Site 2, Berlin

Eisai Trial Site 3, Berlin

Eisai Trial Site 1, Bonn

Eisai Trial Site 2, Bonn

Eisai Trial Site 1, Cologne

Eisai Trial Site 2, Cologne

Eisai Trial Site 1, Darmstadt

Eisai Trial Site 1, Donauwörth

EISAI Trial Site 1, Dresden

Eisai Trial Site 1, Düren

Eisai Trial Site 1, Essen

Eisai Trial Site 1, Esslingen am Neckar

Eisai Trial Site 1, Eutin

Eisai Trial Site 1, Freiburg im Breisgau

Eisai Trial Site 1, Fürstenwalde

Eisai Trial Site 1, Gelsenkirchen

Eisai Trial Site 1, Georgsmarienhütte

Eisai Trial Site 1, Greifswald

Eisai Trial Site 1, Hanover

Eisai Trial Site 2, Hanover

Eisai Trial Site 1, Hof

Eisai Trial Site 1, Homburg

Eisai Trial Site 1, Ilsede

Eisai Trial Site 1, Karlsruhe

Eisai Trial Site 1, Kassel

Eisai Trial Site 1, Kiel

Eisai Trial Site 2, Kiel

Eisai Trial Site 1, Koblenz

Eisai Trial Site 1, Lahr

Eisai Trial Site 1, Landshut

Eisai Trial Site 1, Lemgo

Eisai Trial Site 1, Lübeck

Eisai Trial Site 1, Magdeburg

Eisai Trial Site 1, Mainz

Eisai Trial Site 1, Mannheim

Eisai Trial Site 1, Marktredwitz

Eisai Trial Site 1, München

Eisai Trial Site 2, München

Eisai Trial Site 3, München

Eisai Trial Site 1, Münster

Eisai Trial Site 1, Naunhof

Eisai Trial Site 1, Nuremberg

Eisai Trial Site 1, Oberhausen

Eisai Trial Site 1, Offenbach

Eisai Trial Site 1, Offenburg

Eisai Trial Site 1, Oldenburg

Eisai Trial Site 1, Potsdam

Eisai Trial Site 1, Püttlingen

Eisai Trial Site 1, Quedlinburg

Eisai Trial Site 1, Rodgau

Eisai Trial Site 1, Rotenburg (Wümme)

Eisai Trial Site 1, Saarlouis

Eisai Trial Site 1, Stolberg

Eisai Trial Site 1, Stuttgart

Eisai Trial Site 2, Stuttgart

Eisai Trial Site 1, Tübingen

Eisai Trial Site 1, Villingen-Schwenningen

Eisai Trial Site 1, Worms

All Listed Sponsors
lead

Eisai GmbH

INDUSTRY

NCT03027245 - Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy | Biotech Hunter | Biotech Hunter